US6048729A
(en)
|
1987-05-01 |
2000-04-11 |
Transkaryotic Therapies, Inc. |
In vivo protein production and delivery system for gene therapy
|
US6899882B1
(en)
|
1989-03-24 |
2005-05-31 |
The Regents Of The University Of California |
Endothelial cell growth factor methods of isolation and expression
|
ATE152626T1
(de)
*
|
1989-03-24 |
1997-05-15 |
Univ California |
Endothelialer zellwachsfaktor, isolierung und expression
|
US20030114374A1
(en)
*
|
1989-05-12 |
2003-06-19 |
Genentech, Inc. |
Production of vascular endothelial cell growth factor and DNA encoding same
|
US7300791B2
(en)
*
|
1989-05-12 |
2007-11-27 |
Genentech, Inc. |
Production of vascular endothelial cell growth factor and DNA encoding same
|
US5332671A
(en)
*
|
1989-05-12 |
1994-07-26 |
Genetech, Inc. |
Production of vascular endothelial cell growth factor and DNA encoding same
|
CA2017379C
(en)
*
|
1989-05-24 |
2002-06-25 |
Kenneth A. Thomas, Jr. |
Purification and characterization of a glioma-derived growth factor
|
US5726152A
(en)
*
|
1990-09-21 |
1998-03-10 |
Merck & Co., Inc. |
Vascular endothelial cell growth factor II
|
US6077823A
(en)
*
|
1991-03-11 |
2000-06-20 |
Creative Biomolecules, Inc. |
Method for reducing tissue damage associated with ischemia-reperfusion or hypoxia injury
|
DE69229454T2
(de)
*
|
1991-03-28 |
2000-01-05 |
Merck & Co Inc |
Untereinheit-C des vaskulären endothelialen Zellwachstumsfaktors
|
US6582959B2
(en)
|
1991-03-29 |
2003-06-24 |
Genentech, Inc. |
Antibodies to vascular endothelial cell growth factor
|
US5514779A
(en)
*
|
1991-06-07 |
1996-05-07 |
Zeneca Limited |
Biocidal proteins from plants
|
AU2861692A
(en)
*
|
1991-10-18 |
1993-05-21 |
Beth Israel Hospital Association, The |
Vascular permeability factor targeted compounds
|
ATE238417T1
(de)
*
|
1991-11-04 |
2003-05-15 |
Inst Genetics Llc |
Rekombinante knochenmorphogenetische protein heterodimere, zusammensetzungen und verfahren zur verwendung
|
PT101031B
(pt)
|
1991-11-05 |
2002-07-31 |
Transkaryotic Therapies Inc |
Processo para o fornecimento de proteinas por terapia genetica
|
US6054288A
(en)
*
|
1991-11-05 |
2000-04-25 |
Transkaryotic Therapies, Inc. |
In vivo protein production and delivery system for gene therapy
|
US6692737B1
(en)
|
1991-11-05 |
2004-02-17 |
Transkaryotic Therapies, Inc. |
In vivo protein production and delivery system for gene therapy
|
US6063630A
(en)
|
1991-11-05 |
2000-05-16 |
Transkaryotic Therapies, Inc. |
Targeted introduction of DNA into primary or secondary cells and their use for gene therapy
|
US6749853B1
(en)
|
1992-03-05 |
2004-06-15 |
Board Of Regents, The University Of Texas System |
Combined methods and compositions for coagulation and tumor treatment
|
US5965132A
(en)
|
1992-03-05 |
1999-10-12 |
Board Of Regents, The University Of Texas System |
Methods and compositions for targeting the vasculature of solid tumors
|
US6670178B1
(en)
|
1992-07-10 |
2003-12-30 |
Transkaryotic Therapies, Inc. |
In Vivo production and delivery of insulinotropin for gene therapy
|
US6531124B1
(en)
|
1992-07-10 |
2003-03-11 |
Transkaryotic Therapies, Inc. |
In vivo production and delivery of insulinotropin for gene therapy
|
PT662146E
(pt)
*
|
1992-09-03 |
2000-12-29 |
Univ California |
Factor que afecta o tecido dorsal e composicoes
|
ATE348110T1
(de)
*
|
1992-10-28 |
2007-01-15 |
Genentech Inc |
Hvegf rezeptor als vegf antagonist
|
JPH08508511A
(ja)
*
|
1993-04-29 |
1996-09-10 |
ワシントン・ユニバーシテイー |
副行循環の改善への血小板由来成長因子の使用
|
AU681405B2
(en)
*
|
1993-06-29 |
1997-08-28 |
Chiron Corporation |
A truncated keratinocyte growth factor (KGF) having increased biological activity
|
WO1995006131A1
(en)
*
|
1993-08-23 |
1995-03-02 |
Monash University |
A method for the assay, prophylaxis and/or treatment of human disease conditions
|
US5464815A
(en)
*
|
1993-09-08 |
1995-11-07 |
Genentech, Inc. |
Inhibition of heparin-binding
|
ATE218616T1
(de)
*
|
1993-12-24 |
2002-06-15 |
Forssmann Wolf Georg |
Humanes zirkulierendes cytokin cc-1
|
US5480975A
(en)
*
|
1994-02-08 |
1996-01-02 |
Brigham And Women's Hospital |
Induction of vascular endothelial growth factor (VEGF) by transition metals
|
US5840301A
(en)
*
|
1994-02-10 |
1998-11-24 |
Imclone Systems Incorporated |
Methods of use of chimerized, humanized, and single chain antibodies specific to VEGF receptors
|
US5861499A
(en)
*
|
1994-02-10 |
1999-01-19 |
Imclone Systems Incorporated |
Nucleic acid molecules encoding the variable or hypervariable region of a monoclonal antibody that binds to an extracellular domain
|
US6811779B2
(en)
|
1994-02-10 |
2004-11-02 |
Imclone Systems Incorporated |
Methods for reducing tumor growth with VEGF receptor antibody combined with radiation and chemotherapy
|
US6448077B1
(en)
*
|
1994-02-10 |
2002-09-10 |
Imclone Systems, Inc. |
Chimeric and humanized monoclonal antibodies specific to VEGF receptors
|
US6040157A
(en)
*
|
1994-03-08 |
2000-03-21 |
Human Genome Sciences, Inc. |
Vascular endothelial growth factor 2
|
CA2184584C
(en)
|
1994-03-08 |
2003-04-08 |
Jing-Shan Hu |
Vascular endothelial growth factor 2
|
US6734285B2
(en)
|
1994-03-08 |
2004-05-11 |
Human Genome Sciences, Inc. |
Vascular endothelial growth factor 2 proteins and compositions
|
US7109308B1
(en)
|
1994-03-08 |
2006-09-19 |
Human Genome Sciences, Inc. |
Antibodies to human vascular endothelial growth factor 2
|
US7153827B1
(en)
*
|
1994-03-08 |
2006-12-26 |
Human Genome Sciences, Inc. |
Vascular endothelial growth factor 2 and methods of use
|
US5932540A
(en)
|
1994-03-08 |
1999-08-03 |
Human Genome Sciences, Inc. |
Vascular endothelial growth factor 2
|
US7186688B1
(en)
*
|
1994-03-08 |
2007-03-06 |
Human Genome Sciences, Inc. |
Methods of stimulating angiogenesis in a patient by administering vascular endothelial growth factor 2
|
US6608182B1
(en)
|
1994-03-08 |
2003-08-19 |
Human Genome Sciences, Inc. |
Human vascular endothelial growth factor 2
|
WO1996000286A1
(fr)
*
|
1994-06-27 |
1996-01-04 |
Toagosei Co., Ltd. |
Compose d'acide nucleique antisens
|
US6152141A
(en)
*
|
1994-07-28 |
2000-11-28 |
Heartport, Inc. |
Method for delivery of therapeutic agents to the heart
|
AU3374795A
(en)
*
|
1994-08-29 |
1996-03-22 |
Prizm Pharmaceuticals, Inc. |
Conjugates of vascular endothelial growth factor with targeted agents
|
US6451523B1
(en)
*
|
1994-09-14 |
2002-09-17 |
Interneuron Pharmaceuticals, Inc. |
Detection of a leptin receptor variant and methods for regulating obesity
|
IL114615A0
(en)
*
|
1995-07-16 |
1995-11-27 |
Yeda Res & Dev |
Modulators of the function of fas receptors and other proteins
|
EP0809698B1
(de)
*
|
1995-02-09 |
2001-10-24 |
THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES |
Nukleotid sequenzen und daraus abgleitete aminosäuresequenzen vom tumorgen int 6
|
US6693077B1
(en)
|
1995-02-14 |
2004-02-17 |
Human Genome Sciences, Inc. |
Keratinocyte growth factor-2
|
US6077692A
(en)
|
1995-02-14 |
2000-06-20 |
Human Genome Sciences, Inc. |
Keratinocyte growth factor-2
|
US7232667B2
(en)
*
|
1995-02-14 |
2007-06-19 |
Human Genome Sciences, Inc. |
Keratinocyte growth factor-2 polynucleotides
|
US5928939A
(en)
*
|
1995-03-01 |
1999-07-27 |
Ludwig Institute For Cancer Research |
Vascular endothelial growth factor-b and dna coding therefor
|
US7160991B1
(en)
*
|
1995-03-02 |
2007-01-09 |
Ludwig Institute For Cancer Research |
Vascular endothelial growth factor polypeptides
|
WO1996027007A1
(en)
*
|
1995-03-02 |
1996-09-06 |
Amrad Operations Pty. Ltd. |
A novel growth factor and a genetic sequence encoding same
|
EP0817800A4
(de)
*
|
1995-03-30 |
1999-06-16 |
Human Genome Sciences Inc |
Menschliche g-protein gekoppelte rezeptoren
|
IL117645A
(en)
*
|
1995-03-30 |
2005-08-31 |
Genentech Inc |
Vascular endothelial cell growth factor antagonists for use as medicaments in the treatment of age-related macular degeneration
|
US7429646B1
(en)
|
1995-06-05 |
2008-09-30 |
Human Genome Sciences, Inc. |
Antibodies to human tumor necrosis factor receptor-like 2
|
US7427492B1
(en)
*
|
1995-06-05 |
2008-09-23 |
Human Genome Sciences, Inc. |
Polynucleotides encoding human tumor necrosis factor receptor-like2
|
US20020150578A1
(en)
*
|
1995-06-05 |
2002-10-17 |
Human Genome Sciences, Inc. |
Human prostatic specific reductase
|
US20020026037A1
(en)
*
|
1995-06-06 |
2002-02-28 |
Jing-Shan Hu |
Vascular endothelial growth factor 3 antibodies
|
US6013483A
(en)
*
|
1995-06-07 |
2000-01-11 |
Human Genome Sciences, Inc. |
DNA encoding endothelial monocyte activating polypeptide III
|
US7727761B2
(en)
|
1995-08-01 |
2010-06-01 |
Vegenics Limited |
Vascular endothelial growth factor C (VEGF-C) protein and gene, mutants thereof, and uses thereof
|
AU6777196A
(en)
*
|
1995-08-15 |
1997-03-12 |
Connective Therapeutics Inc. |
Method of promoting angiogenesis
|
DE69628652T3
(de)
|
1995-09-08 |
2012-05-03 |
Genentech, Inc. |
Vegf-verwandtes protein
|
US6329169B1
(en)
*
|
1995-09-29 |
2001-12-11 |
Human Genome Sciences, Inc. |
Nucleic acid molecules encoding cytostatin II
|
DE69638142D1
(de)
*
|
1995-09-29 |
2010-04-15 |
Univ Siena |
Regulierte Gene und ihre Verwendungen
|
WO1997015666A1
(en)
*
|
1995-10-23 |
1997-05-01 |
The Children's Medical Center Corporation |
Therapeutic antiangiogenic compositions and methods
|
US7393943B1
(en)
*
|
1995-12-08 |
2008-07-01 |
Human Genome Sciences, Inc. |
Polynucleotides encoding a human chemotactic cytokine I
|
US7888466B2
(en)
*
|
1996-01-11 |
2011-02-15 |
Human Genome Sciences, Inc. |
Human G-protein chemokine receptor HSATU68
|
US7084252B1
(en)
*
|
1996-01-16 |
2006-08-01 |
The Rockefeller University |
DB, the receptor for leptin
|
US7063958B1
(en)
*
|
1996-01-16 |
2006-06-20 |
The Rockefeller University |
Nucleic acids db, the receptor for leptin
|
US20030185792A1
(en)
*
|
1996-01-22 |
2003-10-02 |
Curis, Inc. |
Morphogen analogs of bone morphogenic proteins
|
US6273598B1
(en)
*
|
1996-01-22 |
2001-08-14 |
Creative Biomolecules, Inc. |
Computer system and methods for producing morphogen analogs of human OP-1
|
US6321109B2
(en)
|
1996-02-15 |
2001-11-20 |
Biosense, Inc. |
Catheter based surgery
|
US7357927B2
(en)
*
|
1996-03-12 |
2008-04-15 |
Human Genome Sciences, Inc. |
Death domain containing receptors
|
US6713061B1
(en)
*
|
1996-03-12 |
2004-03-30 |
Human Genome Sciences, Inc. |
Death domain containing receptors
|
US6410268B1
(en)
*
|
1996-03-18 |
2002-06-25 |
Human Genome Sciences, Inc. |
Polynucleotides encoding chemokine alpha-3
|
US6443974B1
(en)
|
1996-07-28 |
2002-09-03 |
Biosense, Inc. |
Electromagnetic cardiac biostimulation
|
DE69739469D1
(de)
|
1996-08-23 |
2009-07-30 |
Vegenics Ltd |
Rekombinanter vasculärer Endothelzellen Wachstumsfaktor D (VEGF-D)
|
US20030129643A1
(en)
*
|
1996-08-23 |
2003-07-10 |
Human Genome Sciences, Inc. |
T1 receptor-like ligand I
|
CA2235867A1
(en)
*
|
1996-08-27 |
1998-03-05 |
Kyowa Hakko Kogyo Co., Ltd. |
Hematopoietic stem cell growth factor (scgf)
|
US6013780A
(en)
*
|
1996-09-06 |
2000-01-11 |
Technion Research & Development Co. Ltd. |
VEGF145 expression vectors
|
US20070299005A1
(en)
*
|
1996-09-24 |
2007-12-27 |
Tanox, Inc. |
Family of genes encoding apoptosis-related peptides, peptides encoded thereby and methods of use thereof
|
ATE343400T1
(de)
*
|
1996-09-24 |
2006-11-15 |
Merck & Co Inc |
Verbindungen zur hemmung der angiogenese durch gentherapie
|
US20030144202A1
(en)
*
|
1996-10-15 |
2003-07-31 |
Amgen Inc. |
Uses of keratinocyte growth factor-2
|
US6743422B1
(en)
|
1996-10-15 |
2004-06-01 |
Amgen, Inc. |
Keratinocyte growth factor-2 products
|
US6998418B1
(en)
|
1996-11-05 |
2006-02-14 |
Gp Medical, Inc. |
Acellular biological material chemically treated with genipin
|
US20060171907A1
(en)
*
|
1996-11-21 |
2006-08-03 |
The Procter & Gamble Company |
Oral care compositions providing enhanced whitening and stain prevention
|
DE69738841D1
(de)
*
|
1996-12-23 |
2008-08-28 |
Immunex Corp |
Ligand für rezeptor aktivator of nf-kappa b, ligand ist mitglied der tnf superfamilie
|
ATE365796T1
(de)
*
|
1997-01-14 |
2007-07-15 |
Human Genome Sciences Inc |
Tumornekrosefaktor-rezeptoren 6 alpha& 6 beta
|
US20040013664A1
(en)
*
|
1997-01-14 |
2004-01-22 |
Gentz Reiner L. |
Tumor necrosis factor receptors 6 alpha & 6 beta
|
US7285267B2
(en)
*
|
1997-01-14 |
2007-10-23 |
Human Genome Sciences, Inc. |
Tumor necrosis factor receptors 6α & 6β
|
US20030165467A1
(en)
*
|
1997-01-21 |
2003-09-04 |
Technion Research & Development Co., Ltd. |
Angiogenic factor and use thereof in treating cardiovascular disease
|
EP0972022A2
(de)
*
|
1997-01-21 |
2000-01-19 |
Human Genome Sciences, Inc. |
Für rezeptoren kodierende polynukleotide und polypeptide
|
US20020155538A1
(en)
*
|
1997-01-23 |
2002-10-24 |
Incyte Pharmaceuticals, Inc. |
Novel endothelial growth factor
|
AU6267098A
(en)
*
|
1997-02-05 |
1998-08-25 |
Regents Of The University Of California, The |
Morphogenic proteins
|
AU6272098A
(en)
*
|
1997-02-06 |
1998-08-26 |
Human Genome Sciences, Inc. |
Dendritic cell-derived growth factor
|
US6395707B1
(en)
*
|
1997-02-14 |
2002-05-28 |
Genentech, Inc. |
Methods of treatment utilizing variants of vascular endothelial cell growth factor
|
US6485942B1
(en)
|
1997-02-14 |
2002-11-26 |
Genentech, Inc. |
Variants of vascular endothelial cell growth factor having altered pharmacological properties, and recombinant methods of production
|
US20060084082A1
(en)
|
1997-03-07 |
2006-04-20 |
Human Genome Sciences, Inc. |
186 human secreted proteins
|
DE69830320T2
(de)
|
1997-03-07 |
2006-02-02 |
The Wistar Institute Of Anatomy And Biology |
Verwendung von Adenoviralen Vektoren, die PDGF oder VEGF exprimieren, ZUR HEILUNG VON GEWEBSDEFEKTEN UND ZUR INDUZIERUNG DER HYPERVASKULITÄT IN SÄUGERGEWEBEN
|
WO2000047602A1
(en)
*
|
1999-02-10 |
2000-08-17 |
Human Genome Sciences, Inc. |
33 human secreted proteins
|
WO2000075375A1
(en)
*
|
1999-06-07 |
2000-12-14 |
Human Genome Sciences, Inc. |
26 human secreted proteins
|
US7968689B2
(en)
*
|
1997-03-07 |
2011-06-28 |
Human Genome Sciences, Inc. |
Antibodies to HSDEK49 polypeptides
|
US7196164B2
(en)
*
|
1997-07-08 |
2007-03-27 |
Human Genome Sciences, Inc. |
Secreted protein HHTLF25
|
US6951924B2
(en)
*
|
1997-03-14 |
2005-10-04 |
Human Genome Sciences, Inc. |
Antibodies against secreted protein HTEBYII
|
US6541212B2
(en)
*
|
1997-03-10 |
2003-04-01 |
The Regents Of The University Of California |
Methods for detecting prostate stem cell antigen protein
|
US5935813A
(en)
*
|
1997-03-20 |
1999-08-10 |
Incyte Pharmaceuticals, Inc. |
Human pancreatitis-associated protein
|
US20020137890A1
(en)
*
|
1997-03-31 |
2002-09-26 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
WO1998046249A1
(en)
*
|
1997-04-15 |
1998-10-22 |
Radix Organization, Inc. |
Method of treating gastrointestinal ulcers and compositions therefor
|
US7205381B2
(en)
*
|
1997-04-21 |
2007-04-17 |
Schering Corporation |
Mammalian cytokines; related reagents and methods
|
US20030166065A1
(en)
*
|
1997-04-24 |
2003-09-04 |
Human Genome Sciences, Inc. |
Novel integrin ligand ITGL-TSP
|
US7220557B2
(en)
*
|
1997-04-24 |
2007-05-22 |
Human Genome Sciences, Inc. |
METH1 polynucleotides
|
WO1998049309A1
(en)
*
|
1997-04-30 |
1998-11-05 |
F. Hoffmann-La Roche Ag |
Rat st38.2 chemokine
|
US6342369B1
(en)
*
|
1997-05-15 |
2002-01-29 |
Genentech, Inc. |
Apo-2-receptor
|
US6506569B1
(en)
*
|
1997-05-30 |
2003-01-14 |
Human Genome Sciences, Inc. |
Antibodies to human tumor necrosis factor receptor TR10
|
US6031155A
(en)
*
|
1997-06-05 |
2000-02-29 |
Cameron-Mills; Verena |
Arabinoxylan degradation
|
US20060223077A1
(en)
*
|
1997-06-06 |
2006-10-05 |
Human Genome Sciences, Inc. |
207 human secreted proteins
|
US5891674A
(en)
*
|
1997-06-19 |
1999-04-06 |
Incyte Pharmaceuticals, Inc. |
Insulin receptor tyrosine kinase substrate
|
JP2002510974A
(ja)
*
|
1997-06-27 |
2002-04-09 |
ヒューマン ジノーム サイエンシーズ,インコーポレイテッド |
ヒトnk−3関連前立腺特異的遺伝子−1
|
AU8591198A
(en)
*
|
1997-07-31 |
1999-02-22 |
Johns Hopkins University School Of Medicine, The |
Growth differentiation factor-15
|
WO1999006444A1
(en)
*
|
1997-07-31 |
1999-02-11 |
The Johns Hopkins University Of School Of Medicine |
GROWTH DIFFERENTIATION FACTOR, Lefty-1
|
WO1999006443A1
(en)
*
|
1997-07-31 |
1999-02-11 |
The Johns Hopkins University School Of Medicine |
Growth differentiation factor, lefty-2
|
US6416973B1
(en)
*
|
1997-08-01 |
2002-07-09 |
Schering Corporation |
Nucleic acids encoding mammalian cell membrane protein MDL-1
|
WO1999025825A2
(en)
*
|
1997-11-13 |
1999-05-27 |
Genset |
EXTENDED cDNAs FOR SECRETED PROTEINS
|
US20020112251A1
(en)
*
|
1997-08-04 |
2002-08-15 |
Mccarthy Sean A. |
Novel genes encoding proteins having prognostic, diagnostic, preventive, therapeutic and other uses
|
FR2767135B1
(fr)
*
|
1997-08-06 |
2002-07-12 |
Genset Sa |
Recepteur complexe lsr, activite, clonage, et application au diagnostic, a la prevention et/ou au traitement de d'obesite et des risques ou complications associes
|
US6699672B1
(en)
*
|
1997-09-02 |
2004-03-02 |
Insight Biopharmaceuticals Ltd. |
Heparanase specific molecular probes and their use research and medical applications
|
US20030161823A1
(en)
*
|
1998-08-31 |
2003-08-28 |
Neta Ilan |
Therapeutic and cosmetic uses of heparanases
|
US20020088019A1
(en)
*
|
1997-09-02 |
2002-07-04 |
Oron Yacoby-Zeevi |
Methods of and pharmaceutical compositions for improving implantation of embryos
|
US20040213789A1
(en)
*
|
1997-09-02 |
2004-10-28 |
Oron Yacoby-Zeevi |
Heparanase activity neutralizing anti-heparanase monoclonal antibody and other anti-heparanase antibodies
|
US20010006630A1
(en)
*
|
1997-09-02 |
2001-07-05 |
Oron Yacoby-Zeevi |
Introducing a biological material into a patient
|
US6177545B1
(en)
*
|
1997-09-02 |
2001-01-23 |
Insight Strategy & Marketing Ltd. |
Heparanase specific molecular probes and their use in research and medical applications
|
US6849719B2
(en)
*
|
1997-09-17 |
2005-02-01 |
Human Genome Sciences, Inc. |
Antibody to an IL-17 receptor like protein
|
US6482923B1
(en)
*
|
1997-09-17 |
2002-11-19 |
Human Genome Sciences, Inc. |
Interleukin 17-like receptor protein
|
WO1999014240A1
(en)
*
|
1997-09-17 |
1999-03-25 |
Human Genome Sciences, Inc. |
Interleukin-17 receptor-like protein
|
US20030082540A1
(en)
*
|
1997-09-17 |
2003-05-01 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
JP3956272B2
(ja)
*
|
1997-09-22 |
2007-08-08 |
敏男 宮田 |
メグシンタンパク質
|
US7321023B2
(en)
*
|
1997-11-07 |
2008-01-22 |
Incyte Corporation |
SP16 protein
|
US6392019B1
(en)
|
1997-11-22 |
2002-05-21 |
John Ford |
Antibodies specific for EGF motif proteins
|
US6808890B2
(en)
*
|
1999-07-28 |
2004-10-26 |
Nuvelo, Inc. |
Method of detecting a cancerous cell expressing EGFL6, and EGF mutif protein
|
US20060009633A9
(en)
*
|
1997-11-13 |
2006-01-12 |
Genset, S.A. |
Complementary DNAs encoding proteins with signal peptides
|
US20060286639A1
(en)
*
|
1997-11-13 |
2006-12-21 |
Serono Genetics Institute S.A. |
Complementary DNAs encoding proteins with signal peptides
|
WO1999027096A1
(en)
|
1997-11-22 |
1999-06-03 |
Hyseq, Inc. |
A NOVEL EGF MOTIF PROTEIN OBTAINED FROM A cDNA LIBRARY OF FETAL LIVER-SPLEEN
|
US20020132981A1
(en)
*
|
1997-12-03 |
2002-09-19 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
AU1716599A
(en)
*
|
1997-12-08 |
1999-06-28 |
Curis, Inc. |
Human patched genes and proteins, and uses related thereto
|
US6303770B1
(en)
*
|
1997-12-10 |
2001-10-16 |
Zymogenetics, Inc. |
Nucleic acids encoding mammalian alpha helical protein-1
|
US6869927B1
(en)
|
1997-12-22 |
2005-03-22 |
Human Genome Sciences, Inc. |
Keratinocyte growth factor-2 formulations
|
KR20010033484A
(ko)
*
|
1997-12-22 |
2001-04-25 |
휴먼 게놈 사이언시즈, 인크. |
각질세포 성장 인자-2 제제
|
US6703485B2
(en)
*
|
1997-12-23 |
2004-03-09 |
The Trustees Of Columbia University In The City Of New York |
Brain and heart cyclic nucleotide gated ion channel compounds and uses thereof
|
JP2003517265A
(ja)
*
|
1997-12-24 |
2003-05-27 |
ルードヴィッヒ インスティテュート フォー キャンサー リサーチ |
血管内皮増殖因子dを発現する発現ベクターおよび細胞系、およびメラノーマを治療する方法
|
JPH11187884A
(ja)
*
|
1997-12-26 |
1999-07-13 |
Hsp Kenkyusho:Kk |
熱ショック転写因子結合蛋白質
|
US6297367B1
(en)
*
|
1997-12-30 |
2001-10-02 |
Chiron Corporation |
Polynucleotide encoding TNFL1
|
AU2451199A
(en)
*
|
1998-01-07 |
1999-07-26 |
Human Genome Sciences, Inc. |
36 human secreted proteins
|
US20030170213A1
(en)
*
|
1998-01-23 |
2003-09-11 |
Marc F. Charette |
Methods and compositions for enhancing cognitive function using morphogenic proteins
|
US7722671B1
(en)
|
1998-01-27 |
2010-05-25 |
St. Jude Medical, Inc. |
Medical devices with associated growth factors
|
US20030113303A1
(en)
*
|
1998-02-05 |
2003-06-19 |
Yitzhack Schwartz |
Homing of embryonic stem cells to a target zone in tissue using active therapeutics or substances
|
ES2293473T3
(es)
|
1998-02-05 |
2008-03-16 |
Biosense Webster, Inc. |
Administracion intracardiaca de farmaco.
|
US20030129750A1
(en)
*
|
1998-02-05 |
2003-07-10 |
Yitzhack Schwartz |
Homing of donor cells to a target zone in tissue using active therapeutics or substances
|
SG117417A1
(en)
|
1998-02-06 |
2005-12-29 |
Collateral Therpeutics Inc |
Variants of the angiogenic factor vascular endothelial cell growth factor: vegf
|
US6706869B1
(en)
*
|
1998-02-11 |
2004-03-16 |
Wyeth |
Map kinase phosphatases and polynucleotides encoding them
|
US6395890B1
(en)
*
|
1998-02-20 |
2002-05-28 |
Zymogenetics, Inc. |
Nucleic acids encoding connective tissue growth factor homologs
|
US6054276A
(en)
|
1998-02-23 |
2000-04-25 |
Macevicz; Stephen C. |
DNA restriction site mapping
|
US7579160B2
(en)
*
|
1998-03-18 |
2009-08-25 |
Corixa Corporation |
Methods for the detection of cervical cancer
|
US20050026248A1
(en)
*
|
1998-03-26 |
2005-02-03 |
Hsueh Aaron J.W. |
Novel mammalian G-protein coupled receptors having extracellular leucine rich repeat regions
|
DE19813774A1
(de)
*
|
1998-03-27 |
1999-09-30 |
Max Planck Gesellschaft |
Parapockenvirus-kodierter vaskulärer Endothelzell Wachstumsfaktor (PPV-VEGF)
|
US6573095B1
(en)
*
|
1998-04-29 |
2003-06-03 |
Genesis Research & Development Corporation Limited |
Polynucleotides isolated from skin cells
|
EP1652924A3
(de)
*
|
1998-05-14 |
2006-09-13 |
Ono Pharmaceutical Co., Ltd. |
Polypeptide, cDNA, welche diese kodiert und deren Verwendung
|
US20030032061A1
(en)
*
|
1998-05-15 |
2003-02-13 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
US20010023070A1
(en)
*
|
1998-05-29 |
2001-09-20 |
Reinhard Ebner |
Interleukins-21 and 22
|
JP2002516103A
(ja)
*
|
1998-05-29 |
2002-06-04 |
ヒューマン ジノーム サイエンシーズ, インコーポレイテッド |
インターロイキン21およびインターロイキン22
|
AU4411499A
(en)
*
|
1998-06-05 |
1999-12-20 |
Human Genome Sciences, Inc. |
Connective tissue growth factor-4
|
US20070020724A1
(en)
|
1998-06-16 |
2007-01-25 |
Ruben Steven M |
94 human secreted proteins
|
HU226073B1
(en)
*
|
1998-07-14 |
2008-04-28 |
Janssen Pharmaceutica Nv |
Neurotrophic growth factor
|
US7067473B1
(en)
*
|
1998-07-14 |
2006-06-27 |
Janssen Pharmaceutica N.V. |
Neurotrophic growth factor
|
US20070014787A1
(en)
|
1998-07-15 |
2007-01-18 |
Human Genome Sciences, Inc. |
71 human secreted proteins
|
US20050048612A1
(en)
*
|
1998-07-28 |
2005-03-03 |
Incyte Corporation |
Human epidermal proteins HEP1-1 to HEP1-6
|
US6706951B1
(en)
*
|
1998-08-17 |
2004-03-16 |
Pioneer Hi-Bred International, Inc. |
Maize nucleic acid encoding a GDP-mannose pyrophosphorylase
|
AU5551599A
(en)
*
|
1998-08-20 |
2000-03-14 |
Pioneer Hi-Bred International, Inc. |
Compositions and methods for altering an acetyl-coa metabolic pathway of a plant
|
US20030217375A1
(en)
*
|
1998-08-31 |
2003-11-20 |
Eyal Zcharia |
Transgenic animals expressing heparanase and uses thereof
|
WO2000012707A1
(en)
*
|
1998-09-02 |
2000-03-09 |
Millennium Pharmaceuticals, Inc. |
14926 receptor, a novel g-protein coupled receptor
|
EP1417971A3
(de)
*
|
1998-09-09 |
2004-06-30 |
Scios Inc. |
Verwendung eines angiogenen Faktors zur Behandlung von mikrovaskulären Angiopathien
|
DK1112083T3
(da)
*
|
1998-09-09 |
2004-03-08 |
Univ Washington |
Behandling af mikrovaskulære angiopatier
|
US7030083B2
(en)
*
|
1998-09-09 |
2006-04-18 |
University Of Washington |
Treatment of eclampsia and preeclampsia
|
CA2342833A1
(en)
*
|
1998-09-17 |
2000-03-23 |
Incyte Pharmaceuticals, Inc. |
Human gpcr proteins
|
US6680380B1
(en)
*
|
1998-09-18 |
2004-01-20 |
Schering Corporation |
Nucleic acids encoding mammalian interleukin-1ζ, related reagents and methods
|
US20040058355A1
(en)
*
|
1998-09-30 |
2004-03-25 |
Millennium Pharmaceuticals, Inc. |
Novel 21910, 56634, 55053, 2504, 15977, 14760, 25501, 17903, 3700, 21529, 26176, 26343, 56638, 18610, 33217, 21967, H1983, M1983, 38555 or 593 molecules and uses therefor
|
EP1117787A2
(de)
*
|
1998-09-30 |
2001-07-25 |
Millennium Pharmaceuticals, Inc. |
Slgp-protein und korrespondierende nukleinsäurenmoleküle und verwendungen
|
EP1121141A2
(de)
*
|
1998-10-13 |
2001-08-08 |
Chiron Corporation |
Fgf angiogenische wirksäme einheitdosis und verfahren zür ihre verwendung
|
US6440934B1
(en)
|
1998-10-13 |
2002-08-27 |
Chiron Corporation |
Angiogenically effective unit dose of FGF-2 and method of use
|
US20030166550A1
(en)
|
1999-08-27 |
2003-09-04 |
Chiron Corporation |
Angiogenically effective unit dose of FGF-2 and method of use
|
US20020072489A1
(en)
*
|
1998-10-13 |
2002-06-13 |
Whitehouse Martha J. |
Angiogenically effective unit dose of FGF-2 and method of use
|
CA2350785A1
(en)
*
|
1998-11-12 |
2000-05-25 |
Human Genome Sciences, Inc. |
31 human secreted proteins
|
US6375680B1
(en)
|
1998-12-01 |
2002-04-23 |
St. Jude Medical, Inc. |
Substrates for forming synthetic tissues
|
EP1140970A4
(de)
*
|
1998-12-17 |
2003-10-22 |
Human Genome Sciences Inc |
47 menschliche sekretierte proteine
|
US6783953B1
(en)
|
1998-12-22 |
2004-08-31 |
Janssen Pharmaceutica N.V. |
Vascular endothelial growth factor-X
|
JP2000189171A
(ja)
*
|
1998-12-25 |
2000-07-11 |
Banyu Pharmaceut Co Ltd |
新規なグアノシン三リン酸(gtp)結合タンパク質共役型のレセプタ―タンパク質
|
US20030190669A1
(en)
*
|
1998-12-30 |
2003-10-09 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
WO2000043520A2
(en)
*
|
1999-01-25 |
2000-07-27 |
University Of Florida |
Materials and methods for producing geminivirus resistant plants
|
EP1150994A4
(de)
*
|
1999-02-02 |
2003-01-29 |
Univ Columbia |
Gene mit erhöhter expression während zellulärer alterung und terminaler zelldifferenzierung und ihre verwendung
|
US7223724B1
(en)
|
1999-02-08 |
2007-05-29 |
Human Genome Sciences, Inc. |
Use of vascular endothelial growth factor to treat photoreceptor cells
|
DE19906096A1
(de)
*
|
1999-02-13 |
2000-08-17 |
Walter Sebald |
Protein mit einem Heparin-bindenden Epitop
|
US6392126B1
(en)
*
|
1999-02-25 |
2002-05-21 |
Pioneer Hi-Bred International, Inc. |
Adenosine deaminase homologues and uses thereof
|
US6406907B1
(en)
*
|
1999-02-26 |
2002-06-18 |
Iowa State University Research Foundation |
Bovine tumor necrosis factor receptor-1 and methods of use
|
US7083793B2
(en)
*
|
1999-02-26 |
2006-08-01 |
Millennium Pharmaceuticals, Inc. |
Tango 243 polypeptides and uses thereof
|
AU2878600A
(en)
*
|
1999-03-01 |
2000-09-21 |
Hadasit Medical Research Services & Development Company Ltd |
Polynucleotide encoding a polypeptide having heparanase activity and expression of same in genetically modified cells
|
US6783954B2
(en)
*
|
1999-03-05 |
2004-08-31 |
Compugen Ltd. |
VEGF nucleic acid and amino acid sequences
|
IL128852A0
(en)
*
|
1999-03-05 |
2000-01-31 |
Compugen Ltd |
Novel nucleic acid and amino acid sequences
|
US6689866B1
(en)
*
|
1999-03-09 |
2004-02-10 |
Curagen Corporation |
Polynucleotides and proteins encoded thereby
|
US8410248B2
(en)
*
|
1999-03-12 |
2013-04-02 |
Human Genome Sciences Inc. |
HWBAO62 polypeptides
|
US8133734B2
(en)
*
|
1999-03-16 |
2012-03-13 |
Human Genome Sciences, Inc. |
Kit comprising an antibody to interleukin 17 receptor-like protein
|
US6965012B1
(en)
*
|
1999-03-30 |
2005-11-15 |
Eli Lilly And Company |
Flint polypeptide analogs
|
ES2421720T3
(es)
*
|
1999-04-12 |
2013-09-05 |
Genentech Inc |
Homólogos del factor de necrosis tumoral y ácidos nucleicos que los codifican
|
US7345019B1
(en)
*
|
1999-04-13 |
2008-03-18 |
The Kenneth S. Warren Institute, Inc. |
Modulation of excitable tissue function by peripherally administered erythropoietin
|
WO2000064261A1
(en)
*
|
1999-04-26 |
2000-11-02 |
Ludwig Institute For Cancer Research |
Role of vascular endothelial growth factor-b (vegf-b) in developing bones and uses thereof
|
US6524583B1
(en)
|
1999-04-28 |
2003-02-25 |
Board Of Regents, The University Of Texas System |
Antibody methods for selectively inhibiting VEGF
|
WO2000066729A1
(fr)
*
|
1999-04-30 |
2000-11-09 |
Kurokawa, Kiyoshi |
Proteine meg-3
|
AU4986700A
(en)
*
|
1999-05-06 |
2000-11-21 |
National Jewish Medical And Research Center |
Tall-1 nucleic acid molecules, proteins, receptors and methods of use thereof
|
JP2003500053A
(ja)
*
|
1999-05-20 |
2003-01-07 |
サイオス,インコーポレーテッド |
血管内皮増殖因子ダイマー
|
EP1183352A1
(de)
*
|
1999-05-20 |
2002-03-06 |
Scios Inc. |
Varianten vom vaskuläre endothelzellen wachstumsfaktor (vegf)
|
KR20030000011A
(ko)
*
|
1999-05-25 |
2003-01-03 |
휴먼 게놈 사이언시즈, 인크. |
Meth-1 및 meth-2 폴리뉴클레오티드 및폴리펩티드
|
US20030207793A1
(en)
*
|
1999-05-26 |
2003-11-06 |
Conklin Darrell C. |
Secreted alpha-helical protein - 32
|
US6781028B1
(en)
*
|
1999-06-14 |
2004-08-24 |
Exelixis, Inc. |
Animal models and methods for analysis of lipid metabolism and screening of pharmaceutical and pesticidal agents that modulate lipid metabolism
|
US20030153050A1
(en)
*
|
1999-06-28 |
2003-08-14 |
Conklin Darrell C. |
Helical polypeptide zalpha29
|
US20030096355A1
(en)
*
|
1999-07-09 |
2003-05-22 |
Ke Zhang |
Isolation, identification and characterization of ymkz5, a novel member of the TNF-receptor supergene family
|
US6951738B2
(en)
*
|
1999-07-16 |
2005-10-04 |
Human Genome Sciences, Inc. |
Human tumor necrosis factor receptors TR13 and TR14
|
DK1795598T3
(da)
*
|
1999-07-23 |
2010-02-01 |
Kenji Kangawa |
Hidtil ukendte peptider
|
WO2001010891A2
(en)
*
|
1999-08-05 |
2001-02-15 |
Research Corporation Technologies, Inc. |
Il-16 antagonists
|
US20030134788A1
(en)
*
|
1999-08-12 |
2003-07-17 |
Baker Kevin P. |
Human tumor necrosis factor receptor TR16
|
US20040214783A1
(en)
*
|
2002-05-08 |
2004-10-28 |
Terman David S. |
Compositions and methods for treatment of neoplastic disease
|
KR100510795B1
(en)
*
|
1999-08-31 |
2005-08-30 |
|
Compositions and Methods for the Treatment of Tumor
|
US20030120037A1
(en)
*
|
1999-09-22 |
2003-06-26 |
Ji Ming Wang |
Utilization of FPRL1 as a functional receptor by serum amyloid a (SAA)
|
USRE39849E1
(en)
|
1999-10-12 |
2007-09-18 |
Chemocentryx, Inc. |
Methods for identifying modulators of CCX CKR activity
|
US6998239B1
(en)
*
|
1999-10-12 |
2006-02-14 |
Chemocentryx, Inc. |
Method for identifying a modulator of the binding of CCX CKR polypeptide to a chemokine
|
ATE402953T1
(de)
*
|
1999-10-18 |
2008-08-15 |
Lexicon Pharmaceuticals Inc |
Menschliches chordin und polynukleotiden die dafür kodieren
|
US7459308B2
(en)
*
|
1999-10-21 |
2008-12-02 |
Arbor Vita Corporation |
Nucleic acid molecule encoding a CLASP-2 transmembrane protein
|
US6726718B1
(en)
|
1999-12-13 |
2004-04-27 |
St. Jude Medical, Inc. |
Medical articles prepared for cell adhesion
|
US7029857B1
(en)
*
|
1999-12-17 |
2006-04-18 |
H. Lundbeck A/S |
Processes for obtaining compounds employing SNORF72 receptors
|
JP2001211886A
(ja)
*
|
2000-02-07 |
2001-08-07 |
Japan Science & Technology Corp |
L−体及びd−体アミノ酸を輸送するナトリウム非依存性小型中性アミノ酸トランスポーター及びその遺伝子
|
AU3495301A
(en)
*
|
2000-02-11 |
2001-08-20 |
Biogen Inc |
Heterologous polypeptide of the tnf family
|
JP4981229B2
(ja)
|
2000-02-25 |
2012-07-18 |
ルードヴィッヒ インスティテュート フォー キャンサー リサーチ |
ハイブリッド血管内皮成長因子DNAsおよびタンパク質に関与する物質および方法
|
US20030165891A1
(en)
*
|
2000-02-29 |
2003-09-04 |
Millennium Pharmaceuticals, Inc. |
Novel TWIK-6, TWIK-7, IC23927, TWIK-8, IC47611, IC47615, HNMDA-1, TWIK-9 alpha2delta-4, 54414, and 53763 molecules and uses therefor
|
EP1265912A4
(de)
*
|
2000-03-03 |
2004-07-28 |
Univ Utah Res Found |
Das gen mass1 als ziel für die entwicklung antikonvulsiver medkamente
|
US7514239B2
(en)
*
|
2000-03-28 |
2009-04-07 |
Amgen Inc. |
Nucleic acid molecules encoding beta-like glycoprotein hormone polypeptides and heterodimers thereof
|
US20030119739A1
(en)
*
|
2000-03-29 |
2003-06-26 |
Beth Israel Deaconess Medical Center |
Anti-angiogenic and anti-tumor properties of Vascostatin and other nidogen domains
|
US7070946B2
(en)
*
|
2000-05-23 |
2006-07-04 |
Tanabe Seiyaku Co., Ltd. |
Bone metabolism related protein and gene thereof
|
JP2004516005A
(ja)
*
|
2000-05-31 |
2004-06-03 |
オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド |
H4サブタイプの哺乳動物のヒスタミン受容体をコードするdna
|
US20030059461A1
(en)
*
|
2000-06-06 |
2003-03-27 |
Sibtech, Inc. |
Molecular delivery vehicle for delivery of selected compounds to targets
|
US7355019B2
(en)
*
|
2000-06-06 |
2008-04-08 |
Sibtech, Inc. |
Cysteine-containing peptide tag for site-specific conjugation of proteins
|
AU8183601A
(en)
*
|
2000-06-21 |
2002-01-02 |
Merck Patent Gmbh |
A g-protein coupled receptor
|
US7273751B2
(en)
*
|
2000-08-04 |
2007-09-25 |
Human Genome Science, Inc. |
Vascular endothelial growth factor-2
|
WO2002012334A2
(en)
*
|
2000-08-07 |
2002-02-14 |
Zymogenetics, Inc. |
Snake venom polypeptide zsnk1
|
JP2004508043A
(ja)
*
|
2000-09-05 |
2004-03-18 |
アムジェン インコーポレイテッド |
Tnfレセプター様分子およびその使用
|
WO2002030977A2
(en)
*
|
2000-10-13 |
2002-04-18 |
Hyseq, Inc. |
Egf motif protein, egfl6 materials and methods
|
US6489456B1
(en)
*
|
2000-10-27 |
2002-12-03 |
Pe Corporation (Ny) |
Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof
|
GB0028971D0
(en)
*
|
2000-11-28 |
2001-01-10 |
Inpharmatica Ltd |
Novel proteins
|
AU2884102A
(en)
*
|
2000-12-07 |
2002-06-18 |
Sangamo Biosciences Inc |
Regulation of angiogenesis with zinc finger proteins
|
US7067317B2
(en)
*
|
2000-12-07 |
2006-06-27 |
Sangamo Biosciences, Inc. |
Regulation of angiogenesis with zinc finger proteins
|
US20040072997A1
(en)
*
|
2000-12-20 |
2004-04-15 |
Alsobrook John P. |
Therapeutic polypeptides, nucleic acids encoding same, and methods of use
|
US20030072737A1
(en)
*
|
2000-12-29 |
2003-04-17 |
Michael Brines |
Tissue protective cytokines for the protection, restoration, and enhancement of responsive cells, tissues and organs
|
US7767643B2
(en)
|
2000-12-29 |
2010-08-03 |
The Kenneth S. Warren Institute, Inc. |
Protection, restoration, and enhancement of erythropoietin-responsive cells, tissues and organs
|
US20030180309A1
(en)
*
|
2001-01-08 |
2003-09-25 |
Baum Peter R. |
Human B7 polypeptides
|
US20030186904A1
(en)
*
|
2001-01-08 |
2003-10-02 |
Human Genome Sciences, Inc. |
Keratinocyte growth factor-2
|
US7442370B2
(en)
*
|
2001-02-01 |
2008-10-28 |
Biogen Idec Ma Inc. |
Polymer conjugates of mutated neublastin
|
US20030114371A1
(en)
*
|
2001-02-07 |
2003-06-19 |
Feder John N. |
Polynucleotide encoding a novel human potassium channel beta-subunit, K+betaM3
|
TWI329129B
(en)
*
|
2001-02-08 |
2010-08-21 |
Wyeth Corp |
Modified and stabilized gdf propeptides and uses thereof
|
NZ528320A
(en)
*
|
2001-02-23 |
2005-07-29 |
Wyeth Corp |
Composition for inducing cartilaginous tissue formation and maintenance comprising a non-culture expanded CD105+ cells and a BMP
|
US7276580B2
(en)
*
|
2001-03-12 |
2007-10-02 |
Biogen Idec Ma Inc. |
Neurotrophic factors
|
US7741049B2
(en)
*
|
2001-03-15 |
2010-06-22 |
Sumitomo Chemical Company, Limited |
Analysis of agonist-activity and antagonist-activity to cytokinin receptor
|
US6962971B2
(en)
*
|
2001-03-16 |
2005-11-08 |
The Regents Of The University Of California |
Chemokines and methods for inducing the differentiation of fibroblasts to myofibroblasts
|
WO2002076494A2
(en)
*
|
2001-03-23 |
2002-10-03 |
Biopharm Gesellschaft Zur Biotechnologischen Entwicklung Von Pharmaka Mbh |
USE OF CYTOKINES OF THE TGF-β SUPERFAMILY FOR THE TREATMENT AND DIAGNOSIS OF SKIN RELATED DISORDERS
|
US20030027751A1
(en)
*
|
2001-04-10 |
2003-02-06 |
Genvec, Inc. |
VEGF fusion proteins
|
AU2002303340A1
(en)
*
|
2001-04-10 |
2002-10-28 |
Agensys, Inc. |
Nucleic acid and corresponding protein entitled 184p1e2 useful in treatment and detection of cancer
|
US7795218B2
(en)
*
|
2001-04-12 |
2010-09-14 |
Bioaxone Therapeutique Inc. |
ADP-ribosyl transferase fusion variant proteins
|
AU2002256172A1
(en)
*
|
2001-04-13 |
2002-10-28 |
Human Genome Sciences, Inc. |
Vascular endothelial growth factor 2
|
US7402312B2
(en)
*
|
2001-04-13 |
2008-07-22 |
Human Genome Sciences, Inc. |
Antibodies to vascular endothelial growth factor 2 (VEGF-2)
|
EP1385862A4
(de)
*
|
2001-04-13 |
2005-03-02 |
Human Genome Sciences Inc |
Vaskulärer endothelwachstumsfaktor 2
|
US20050232921A1
(en)
*
|
2001-04-13 |
2005-10-20 |
Rosen Craig A |
Vascular endothelial growth factor 2
|
JP2004536579A
(ja)
|
2001-04-13 |
2004-12-09 |
ヒューマン ジノーム サイエンシーズ, インコーポレイテッド |
血管内皮増殖因子2
|
US6878729B2
(en)
*
|
2001-05-04 |
2005-04-12 |
The Procter & Gamble Company |
Medicinal uses of dihydropyrazoles
|
US6660737B2
(en)
|
2001-05-04 |
2003-12-09 |
The Procter & Gamble Company |
Medicinal uses of hydrazones
|
GB0119015D0
(en)
*
|
2001-08-03 |
2001-09-26 |
Univ Cardiff |
A fusion protein
|
EP1423426A1
(de)
*
|
2001-08-15 |
2004-06-02 |
Endocube SAS |
Sut-2 und sut-3 gene, proteine und testverfahren für inhibitoren der lymphozytenadhäsion
|
PL374269A1
(en)
*
|
2001-08-21 |
2005-10-03 |
Chiron Corporation |
Kgf polypeptide compositions
|
US7217570B2
(en)
*
|
2001-08-23 |
2007-05-15 |
The Wistar Institute Of Anatomy And Biology |
Organotypic intestinal culture and methods of use thereof
|
MXPA04001986A
(es)
*
|
2001-08-29 |
2004-06-07 |
Genentech Inc |
Composiciones y metodos para el tratamiento de enfermedades relacionadas a la inmunidad.
|
US20050222070A1
(en)
*
|
2002-05-29 |
2005-10-06 |
Develogen Aktiengesellschaft Fuer Entwicklungsbiologische Forschung |
Pancreas-specific proteins
|
US20040214766A1
(en)
*
|
2001-10-01 |
2004-10-28 |
Kari Alitalo |
VEGF-C or VEGF-D materials and methods for treatment of neuropathologies
|
US20040031067A1
(en)
*
|
2001-10-11 |
2004-02-12 |
Meenhard Herlyn |
Regulation of human skin healing
|
CA2463596A1
(en)
*
|
2001-10-12 |
2003-04-24 |
Yamanouchi Pharmaceutical Co., Ltd. |
Method of screening cell death inhibitor
|
EP1578907A2
(de)
*
|
2001-10-17 |
2005-09-28 |
ZymoGenetics, Inc. |
Sezerniertes protein, ztnf9
|
US7371258B2
(en)
*
|
2001-10-26 |
2008-05-13 |
St. Jude Medical, Inc. |
Valved prosthesis with porous substrate
|
US6671189B2
(en)
*
|
2001-11-09 |
2003-12-30 |
Minebea Co., Ltd. |
Power converter having primary and secondary side switches
|
US20030093147A1
(en)
*
|
2001-11-13 |
2003-05-15 |
Ogle Matthew F. |
Medical devices that stimulate growth factor production
|
US20050137130A1
(en)
*
|
2001-11-14 |
2005-06-23 |
Bodmer Mark W. |
Medical treatment
|
EP1474176A4
(de)
*
|
2001-11-26 |
2005-06-15 |
Bristol Myers Squibb Co |
Neuer menschlicher g-protein-gekoppelter rezeptor hgprbmy31 sowie varianten davon und verwendungsverfahren dafür
|
US20030104496A1
(en)
*
|
2001-11-30 |
2003-06-05 |
Cytokinetics, Inc. |
Novel motor protein of P. falciparum and methods for its use
|
US20030171556A1
(en)
*
|
2001-12-13 |
2003-09-11 |
Chi-Bom Chae |
Beta-amyloid binding factors and inhibitors thereof
|
US7795213B2
(en)
*
|
2001-12-13 |
2010-09-14 |
Posco |
Methods of contacting β amyloid protein with VEGF
|
CA2472927A1
(en)
*
|
2002-01-10 |
2003-07-17 |
Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw |
A novel splice variant of myd88 and uses thereof
|
US20040162237A1
(en)
*
|
2002-01-15 |
2004-08-19 |
Fox Niles Wayne |
Use of lp82 to treat body weight disorders
|
KR20030062788A
(ko)
|
2002-01-19 |
2003-07-28 |
포휴먼텍(주) |
생체분자 전달 펩타이드 mph1-btm 및 이것을포함하는 생명공학제품
|
KR20030062789A
(ko)
|
2002-01-19 |
2003-07-28 |
포휴먼텍(주) |
생체분자 전달 펩타이드 sim2-btm 및 이것을포함하는 생명공학제품
|
CA2473853A1
(en)
*
|
2002-01-23 |
2003-08-14 |
J. Suzanne Lindsey |
Mammalian migration inducting gene and methods for detection and inhibition of migrating tumor cells
|
EP1474515A2
(de)
*
|
2002-02-01 |
2004-11-10 |
Bayer HealthCare AG |
Regulierung eines menschlichen hematopoietin rezeptor ähnlichen proteins
|
GB0202906D0
(en)
*
|
2002-02-07 |
2002-03-27 |
Univ London |
Prevention of myocardial damage
|
WO2003077652A1
(en)
*
|
2002-03-12 |
2003-09-25 |
Harold Brem |
Method for treating diabetic ulcers
|
EP1530590A2
(de)
*
|
2002-03-22 |
2005-05-18 |
Bioxell S.p.a. |
Triggering receptors expressed on myeloid cells (trem)-4 und -5 und deren verwendung
|
WO2003083113A2
(en)
*
|
2002-03-28 |
2003-10-09 |
The Genetics Company |
Growth regulating proteins
|
CA2482718C
(en)
*
|
2002-04-18 |
2014-08-19 |
Yeda Research And Development Co. Ltd. |
Derivatives of the il-2 receptor gamma chain, their production and use
|
WO2003091282A1
(fr)
*
|
2002-04-24 |
2003-11-06 |
Banyu Pharmaceutical Co., Ltd. |
Mutant a activite ordinaire du recepteur h3 de l'histamine et utilisation correspondante
|
US20030055221A1
(en)
*
|
2002-05-07 |
2003-03-20 |
Jirong Lu |
Stability of flint through o-linked glycosylation
|
EP1382613A1
(de)
*
|
2002-07-16 |
2004-01-21 |
Sumitomo Chemical Company, Limited |
Neues G Protein, kodierende Nukleotidsequenzen und Verwendung des Proteins
|
US7335362B2
(en)
|
2002-07-19 |
2008-02-26 |
Beth Israel Deaconess Medical Center |
Methods of treating pre-eclampsia or eclampsia
|
US7435419B2
(en)
|
2002-07-19 |
2008-10-14 |
Beth Israel Deaconess Medical Center |
Methods of diagnosing and treating pre-eclampsia or eclampsia
|
PT1575416E
(pt)
*
|
2002-07-19 |
2014-01-08 |
Beth Israel Hospital |
Métodos para o diagnóstico e o tratamento de pré-eclâmpsia ou eclâmpsia
|
GB0219303D0
(en)
*
|
2002-08-19 |
2002-09-25 |
Ares Trading Sa |
Protein
|
JP2006515177A
(ja)
*
|
2002-09-10 |
2006-05-25 |
ロランティス リミテッド |
Notchリガンドタンパク質を含む医薬組成物及び医学的処置
|
ES2416510T3
(es)
*
|
2002-10-08 |
2013-08-01 |
Ares Trading S.A. |
Uso de una citocina capaz de unirse a IL 18BP y de inhibir la actividad de una segunda citocina
|
GB0223984D0
(en)
*
|
2002-10-15 |
2002-11-20 |
Novartis Forschungsstiftung |
Methods for detecting teneurin signalling and related screening methods
|
US20040223966A1
(en)
*
|
2002-10-25 |
2004-11-11 |
Wolfman Neil M. |
ActRIIB fusion polypeptides and uses therefor
|
JP4571776B2
(ja)
*
|
2002-11-05 |
2010-10-27 |
Jx日鉱日石エネルギー株式会社 |
潤滑油組成物
|
US7060684B1
(en)
|
2002-12-16 |
2006-06-13 |
Quijano Rodolfo C |
Device for treating diabetes and methods thereof
|
US20040120950A1
(en)
*
|
2002-12-20 |
2004-06-24 |
Kari Alitalo |
Modulation of VEGF-C/VEGFR-3 interactions in the treatment of rheumatoid arthritis
|
US20040235747A1
(en)
*
|
2003-01-02 |
2004-11-25 |
Ramot At Tel-Aviv University Ltd. |
Methods of treating and/or preventing autoimmune diseases
|
US20060276385A1
(en)
*
|
2003-01-13 |
2006-12-07 |
Hanjoong Jo |
Anti-inflammatory agents and methods of their use
|
JP2006519004A
(ja)
*
|
2003-02-05 |
2006-08-24 |
アプライド リサーチ システムズ エーアールエス ホールディング ナームロゼ フェンノートシャップ |
新規ムチン様ポリペプチド
|
DE602004027798D1
(de)
*
|
2003-03-12 |
2010-08-05 |
Univ Arizona State |
Verfahren zur regulierung von angiogenese mit apelin-zusammensetzungen
|
US7084246B2
(en)
*
|
2003-04-17 |
2006-08-01 |
Molecular Logix, Inc. |
Epidermal growth factor agonists
|
CA2864810A1
(en)
|
2003-04-18 |
2004-11-04 |
Biogen Idec Ma, Inc. |
Polymer-conjugated glycosylated neublastin
|
TWI353991B
(en)
|
2003-05-06 |
2011-12-11 |
Syntonix Pharmaceuticals Inc |
Immunoglobulin chimeric monomer-dimer hybrids
|
US7344716B2
(en)
*
|
2003-05-13 |
2008-03-18 |
Depuy Spine, Inc. |
Transdiscal administration of specific inhibitors of pro-inflammatory cytokines
|
US20040229878A1
(en)
*
|
2003-05-13 |
2004-11-18 |
Depuy Spine, Inc. |
Transdiscal administration of specific inhibitors of P38 kinase
|
US8273347B2
(en)
|
2003-05-13 |
2012-09-25 |
Depuy Spine, Inc. |
Autologous treatment of degenerated disc with cells
|
US7429378B2
(en)
*
|
2003-05-13 |
2008-09-30 |
Depuy Spine, Inc. |
Transdiscal administration of high affinity anti-MMP inhibitors
|
US7553827B2
(en)
*
|
2003-08-13 |
2009-06-30 |
Depuy Spine, Inc. |
Transdiscal administration of cycline compounds
|
US20050054829A1
(en)
*
|
2003-07-22 |
2005-03-10 |
Wiley Steven R. |
Compositions and methods relating to TSP-30a, b, c and d
|
KR100632985B1
(ko)
*
|
2003-07-26 |
2006-10-11 |
메덱스젠 주식회사 |
생리활성 조절 단백질의 효능 향상 방법 및 그 예시변이체들
|
US8361467B2
(en)
*
|
2003-07-30 |
2013-01-29 |
Depuy Spine, Inc. |
Trans-capsular administration of high specificity cytokine inhibitors into orthopedic joints
|
AU2004268614C1
(en)
*
|
2003-08-27 |
2010-10-28 |
Ophthotech Corporation |
Combination therapy for the treatment of ocular neovascular disorders
|
US8283307B2
(en)
*
|
2003-09-08 |
2012-10-09 |
Merck Serono Sa |
Treatment of fibrotic disease
|
JP4664815B2
(ja)
*
|
2003-09-11 |
2011-04-06 |
ヒュービットジェノミクス株式会社 |
硬化をもたらす増殖性疾患の検出方法及びキット、硬化をもたらす増殖性疾患の予防及び/又は治療剤、ならびに硬化をもたらす増殖性疾患の予防及び/又は治療に有効な物質を同定する方法及びキット
|
US7645733B2
(en)
*
|
2003-09-29 |
2010-01-12 |
The Kenneth S. Warren Institute, Inc. |
Tissue protective cytokines for the treatment and prevention of sepsis and the formation of adhesions
|
WO2005040194A2
(en)
*
|
2003-10-24 |
2005-05-06 |
Ludwig Institute For Cancer Research |
Methods and compositions for pdgf-c activation and inhibition
|
EP2385069A3
(de)
|
2003-11-12 |
2012-05-30 |
Biogen Idec MA Inc. |
Neonataler Fc-Rezeptor (FcRn)-bindende Polypeptidvarianten, dimere Fc-Bindungsproteine und damit in Zusammenhang stehende Verfahren
|
WO2005051994A2
(en)
*
|
2003-11-21 |
2005-06-09 |
Zymogenetics, Inc. |
Ztnf11, a tumor necrosis factor
|
US8895540B2
(en)
|
2003-11-26 |
2014-11-25 |
DePuy Synthes Products, LLC |
Local intraosseous administration of bone forming agents and anti-resorptive agents, and devices therefor
|
JP2007535307A
(ja)
*
|
2003-12-16 |
2007-12-06 |
ザイモジェネティクス,インコーポレイティド |
腫瘍壊死因子Ztnf12
|
BRPI0418286A
(pt)
|
2003-12-30 |
2007-05-02 |
Merck Patent Gmbh |
proteìnas de fusão de il-7
|
US20050176073A1
(en)
*
|
2004-02-06 |
2005-08-11 |
Chemocentryx, Inc. |
Cell proliferation associated with CCX CKR expression
|
AU2005244167A1
(en)
*
|
2004-05-04 |
2005-11-24 |
Beth Israel Deaconess Medical Center |
Methods and compositions for treatment of preeclampsia
|
EP1612892B1
(de)
*
|
2004-06-30 |
2008-03-19 |
Tyco Electronics Nederland B.V. |
Verbinder für elektronische Bauteile
|
US7597884B2
(en)
*
|
2004-08-09 |
2009-10-06 |
Alios Biopharma, Inc. |
Hyperglycosylated polypeptide variants and methods of use
|
JP2008513356A
(ja)
*
|
2004-08-09 |
2008-05-01 |
アリオス バイオファーマ インク. |
合成高度糖鎖付加プロテアーゼ耐性ポリペプチド変異体、それを使用する経口製剤および方法
|
SE0402025D0
(sv)
*
|
2004-08-13 |
2004-08-13 |
Active Biotech Ab |
Treatment of hyperproliferative disease with superantigens in combination with another anticancer agent
|
EP1796716A4
(de)
*
|
2004-08-13 |
2010-09-08 |
Anormed Inc |
Chemokin-kombinationen zur mobilisierung von vorläufer/stammzellen
|
ATE474586T1
(de)
*
|
2004-08-19 |
2010-08-15 |
Biogen Idec Inc |
Neublastin-varianten
|
AR050608A1
(es)
*
|
2004-08-19 |
2006-11-08 |
Alza Corp |
Aparato y metodo para administracion transdermica de factores de crecimiento endotelial vascular
|
AU2005277227B2
(en)
|
2004-08-19 |
2011-10-06 |
Biogen Ma Inc. |
Refolding transforming growth factor beta family proteins
|
US20070166281A1
(en)
*
|
2004-08-21 |
2007-07-19 |
Kosak Kenneth M |
Chloroquine coupled antibodies and other proteins with methods for their synthesis
|
US20080171033A1
(en)
*
|
2004-08-26 |
2008-07-17 |
Chiwen Chang |
Compositions and methods for treating diseases associated with angiogenesis and inflammation
|
SG155257A1
(en)
|
2004-09-24 |
2009-09-30 |
Beth Israel Hospital |
Methods of diagnosing and treating complications of pregnancy
|
US7740849B2
(en)
*
|
2004-09-24 |
2010-06-22 |
Beth Israel Deaconess Medical Center |
Use of compounds that bind soluble endoglin and SFLT-1 for the treatment of pregnancy related hypertensive disorders
|
US20060090646A1
(en)
*
|
2004-11-04 |
2006-05-04 |
Questair Technologies Inc. |
Adsorbent material for selective adsorption of carbon monoxide and unsaturated hydrocarbons
|
US7939267B2
(en)
*
|
2004-11-04 |
2011-05-10 |
Laboratory Corporation Of America Holdings |
Detection of activation of endothelial cells as surrogate marker for angiogenesis
|
PT1819358E
(pt)
|
2004-11-18 |
2014-11-17 |
Imclone Llc |
Anticorpos contra o recetor-1 do factor de crescimento endotelial vascular
|
US20080026410A1
(en)
*
|
2004-12-02 |
2008-01-31 |
Antonia Vlahou |
Biomarkers for Bladder Cancer
|
EP1839057B1
(de)
*
|
2004-12-15 |
2010-08-25 |
Beth Israel Deaconess Medical Center |
Nukleinsäuren und polypeptide zur diagnose und behandlung von schwangerschaftskomplikationen
|
KR20070100346A
(ko)
|
2005-01-05 |
2007-10-10 |
바이오겐 아이덱 엠에이 인코포레이티드 |
크립토 결합 분자
|
WO2006094106A2
(en)
|
2005-02-28 |
2006-09-08 |
Sangamo Biosciences, Inc. |
Anti-angiogenic methods and compositions
|
JP2008533114A
(ja)
*
|
2005-03-18 |
2008-08-21 |
ユーシーエル ビジネス パブリック リミテッド カンパニー |
メカノ成長因子ペプチドおよびその使用
|
WO2006107611A2
(en)
*
|
2005-03-23 |
2006-10-12 |
Wyeth |
Detection of an immune response to gdf-8 modulating agents
|
US7767789B2
(en)
*
|
2005-06-02 |
2010-08-03 |
University Hopitals of Cleveland |
Truncated proteins as cancer markers
|
WO2006138646A2
(en)
*
|
2005-06-17 |
2006-12-28 |
The Brigham And Women's Hospital, Inc. |
Protein profile for osteoarthritis
|
EP1904094A2
(de)
*
|
2005-06-17 |
2008-04-02 |
Genentech, Inc. |
Verwendung von vegf zur wundheilung
|
WO2007024752A2
(en)
*
|
2005-08-26 |
2007-03-01 |
Beth Israel Deaconess Medical Center |
Methods and compositions for the treatment and diagnosis of endothelial cell disorders and angiogenic disorders
|
EP1973942B1
(de)
|
2005-12-22 |
2011-02-09 |
Genentech, Inc. |
Rekombinante produktion heparinbindender proteine
|
US7659250B2
(en)
*
|
2005-12-22 |
2010-02-09 |
Centocor, Inc. |
BMP-7 variant compositions, methods and uses
|
US20080064631A1
(en)
*
|
2006-01-13 |
2008-03-13 |
Jeffrey Molldrem |
T-cell receptors for use in diagnosis and therapy of cancers and autoimmune disease
|
TWI501774B
(zh)
*
|
2006-02-27 |
2015-10-01 |
Biogen Idec Inc |
神經性病症之治療
|
EP1993590B1
(de)
*
|
2006-03-01 |
2013-12-25 |
Biogen Idec MA Inc. |
Zusammensetzungen und verfahren zur verabreichung von proteinen der gdnf-liganden-familie
|
US9878003B2
(en)
|
2006-03-06 |
2018-01-30 |
The University Of Manchester |
Method of treating bone disorders using TSG-6
|
GB0604460D0
(en)
*
|
2006-03-06 |
2006-04-12 |
Isis Innovation |
Treatment
|
US8101564B2
(en)
*
|
2006-05-03 |
2012-01-24 |
Trustees Of The University Of Pennsylvania |
Methods for regulating osteoclast differentiation and bone resorption using LRRc17
|
AU2007254243B2
(en)
|
2006-05-17 |
2013-06-13 |
Ludwig Institute For Cancer Research |
Targeting VEGF-B regulation of fatty acid transporters to modulate human diseases
|
US20090286271A1
(en)
*
|
2006-05-31 |
2009-11-19 |
Karumanchi Ananth S |
Methods of Diagnosing and Treating Complications of Pregnancy
|
WO2008004972A2
(en)
*
|
2006-07-04 |
2008-01-10 |
Combigene Ab |
Use of nucleic acid sequences for the treatment of neurological and psychiatric diseases, vectors and compositions
|
JP5566104B2
(ja)
|
2006-07-14 |
2014-08-06 |
ジェネンテック, インコーポレイテッド |
組み換えタンパク質の再折り畳み
|
AU2007281677A1
(en)
*
|
2006-08-07 |
2008-02-14 |
Genzyme Corporation |
Combination therapy
|
US9023352B2
(en)
|
2007-02-20 |
2015-05-05 |
Tufts University |
Methods, compositions and kits for treating a subject using a recombinant heteromultimeric neutralizing binding protein
|
US8865169B2
(en)
*
|
2007-02-20 |
2014-10-21 |
Tufts University |
Methods and systems for multi-antibody therapies
|
KR100984483B1
(ko)
*
|
2007-03-19 |
2010-10-01 |
(주)바이오니아 |
순환적 역전사 방법
|
US20080234194A1
(en)
*
|
2007-03-20 |
2008-09-25 |
Harold Brem |
Growth factor mediated cosmeceuticals and use thereof to enhance skin quality
|
EP2139447A2
(de)
*
|
2007-03-20 |
2010-01-06 |
Harold Brem |
Gm-csf-kosmezeutikazusammensetzungen und verfahren zu ihrer verwendung
|
US20080260820A1
(en)
*
|
2007-04-19 |
2008-10-23 |
Gilles Borrelly |
Oral dosage formulations of protease-resistant polypeptides
|
JP5583005B2
(ja)
|
2007-05-01 |
2014-09-03 |
バイオジェン・アイデック・エムエイ・インコーポレイテッド |
血管新生を増大させるための組成物および方法
|
US20110135648A1
(en)
*
|
2007-08-08 |
2011-06-09 |
Biogen Idec Ma Inc. |
Anti-neublastin antibodies and uses thereof
|
US20090162351A1
(en)
*
|
2007-12-21 |
2009-06-25 |
Depuy Spine, Inc. |
Transdiscal administration of inhibitors of p38 MAP kinase
|
US8986696B2
(en)
*
|
2007-12-21 |
2015-03-24 |
Depuy Mitek, Inc. |
Trans-capsular administration of p38 map kinase inhibitors into orthopedic joints
|
AU2009233718A1
(en)
*
|
2008-04-09 |
2009-10-15 |
Ludwig Institute For Cancer Research |
Regulation of fatty acid transporters
|
EP2310507A4
(de)
|
2008-07-08 |
2013-03-20 |
David Gladstone Inst |
Verfahren und zusammensetzungen zur angiogenesemodulierung
|
US20120190042A1
(en)
*
|
2009-01-22 |
2012-07-26 |
Reuben Gobezie |
Protein biomarkers and therapeutic targets for osteoarthritis
|
ES2575695T3
(es)
|
2009-03-30 |
2016-06-30 |
Acceleron Pharma Inc. |
Antagonistas de BMP-ALK3 y sus usos para estimular el crecimiento óseo
|
EP2427572B1
(de)
*
|
2009-05-01 |
2013-08-28 |
Illumina, Inc. |
Sequenzierungsverfahren
|
EP2445512B1
(de)
*
|
2009-06-23 |
2018-08-29 |
The Regents of The University of California |
Verbesserung der bmp-aufrechterhaltung
|
US9409983B2
(en)
*
|
2009-07-23 |
2016-08-09 |
The Board Of Trustess Of The University Of Illinois |
Methods and compositions involving PBEF inhibitors for lung inflammation conditions and diseases
|
CA2790203C
(en)
*
|
2010-02-19 |
2019-05-14 |
Norman Latov |
Inhibitor of macrophage scavenger receptor 1 (msr1) for the treatment of autoimmune demyelinating diseases
|
JP5616973B2
(ja)
*
|
2010-02-26 |
2014-10-29 |
オステムインプラント カンパニー リミテッド |
造骨細胞の分化能を高めるオリゴペプチド
|
US20110218141A1
(en)
*
|
2010-03-03 |
2011-09-08 |
Hamrick Mark W |
Leptin therapy to increase muscle mass and to treat muscle wasting conditions
|
US8969322B2
(en)
|
2010-05-14 |
2015-03-03 |
Beth Israel Deconess Medical Center, Inc. |
Extracorporeal devices and methods of treating complications of pregnancy
|
WO2011160062A2
(en)
*
|
2010-06-17 |
2011-12-22 |
The Usa As Represented By The Secretary, National Institutes Of Health |
Compositions and methods for treating inflammatory conditions
|
NZ605400A
(en)
|
2010-07-09 |
2015-05-29 |
Biogen Idec Hemophilia Inc |
Chimeric clotting factors
|
US20120171769A1
(en)
*
|
2010-12-30 |
2012-07-05 |
Mcgonigle Joseph S |
Cell attachment coatings and methods
|
WO2013012733A1
(en)
|
2011-07-15 |
2013-01-24 |
Biogen Idec Ma Inc. |
Heterodimeric fc regions, binding molecules comprising same, and methods relating thereto
|
US8507446B2
(en)
*
|
2011-08-09 |
2013-08-13 |
Mackay Memorial Hospital |
Use of PEDF-derived polypeptides for treating liver cirrhosis
|
LT2802606T
(lt)
|
2012-01-10 |
2018-10-10 |
Biogen Ma Inc. |
Terapinių molekulių transporto per kraujo-smegenų barjerą padidinimas
|
US9920295B2
(en)
*
|
2012-02-21 |
2018-03-20 |
The Trustees Of The University Of Pennsylvania |
Bioreactor for isolation of rare cells and methods of use
|
EP2830646B1
(de)
|
2012-03-27 |
2018-03-07 |
NGM Biopharmaceuticals, Inc. |
Zusammensetzungen und verfahren zur behandlung von stoffwechselerkrankungen
|
US9133440B2
(en)
*
|
2012-09-27 |
2015-09-15 |
Claresa Levetan |
Generation of new pancreatic beta cells
|
US9161966B2
(en)
|
2013-01-30 |
2015-10-20 |
Ngm Biopharmaceuticals, Inc. |
GDF15 mutein polypeptides
|
JP6272907B2
(ja)
|
2013-01-30 |
2018-01-31 |
エヌジーエム バイオファーマシューティカルズ インコーポレイテッド |
代謝障害の処置における組成物及び使用方法
|
SG10201913874TA
(en)
|
2013-03-15 |
2020-03-30 |
Biogen Ma Inc |
Factor ix polypeptide formulations
|
CN110193009A
(zh)
|
2013-07-12 |
2019-09-03 |
伊维希比奥公司 |
用于治疗或预防眼科病的方法
|
CA2933552A1
(en)
*
|
2013-12-23 |
2015-07-02 |
Alk-Abello A/S |
Peptide combinations and uses thereof in treating dust mite allergy
|
PE20170771A1
(es)
|
2014-07-30 |
2017-07-04 |
Ngm Biopharmaceuticals Inc |
Composiciones y metodos de uso para tratar trastornos metabolicos
|
EP3701969A1
(de)
|
2014-10-31 |
2020-09-02 |
NGM Biopharmaceuticals, Inc. |
Zusammensetzungen und verfahren zur verwendung zur behandlung von stoffwechselerkrankungen
|
EP3954993A1
(de)
|
2015-02-04 |
2022-02-16 |
Bristol-Myers Squibb Company |
Verfahren zur auswahl therapeutischer moleküle
|
CN107922946A
(zh)
|
2015-02-04 |
2018-04-17 |
霍夫曼-拉罗奇有限公司 |
Tau反义低聚物及其用途
|
ES2901455T3
(es)
|
2015-04-03 |
2022-03-22 |
Univ Massachusetts |
Compuestos oligonucleotídicos para el tratamiento de preeclampsia y otros trastornos angiogénicos
|
JP2019503394A
(ja)
|
2016-01-31 |
2019-02-07 |
ユニバーシティ・オブ・マサチューセッツUniversity Of Massachusetts |
分岐オリゴヌクレオチド
|
KR102370762B1
(ko)
|
2016-03-31 |
2022-03-04 |
엔지엠 바이오파마슈티컬스, 아이엔씨. |
결합 단백질 및 이의 사용 방법
|
WO2018031933A2
(en)
|
2016-08-12 |
2018-02-15 |
University Of Massachusetts |
Conjugated oligonucleotides
|
CA3109133A1
(en)
|
2018-08-10 |
2020-02-13 |
University Of Massachusetts |
Modified oligonucleotides targeting snps
|
AU2022299169A1
(en)
|
2021-06-23 |
2024-02-08 |
Beth Israel Deaconess Medical Center, Inc. |
Optimized anti-flt1 oligonucleotide compounds for treatment of preeclampsia and other angiogenic disorders
|